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Letter to Am Heart Journal  
ĂƌĚŝĂĐƌĞŚĂďŝůŝƚĂƚŝŽŶŝŶŚĞĂƌƚĨĂŝůƵƌĞǁŝƚŚƌĞĚƵĐĞĚĞũĞĐƚŝŽŶĨƌĂĐƚŝŽŶ ? ?should take it and not leave 
ŝƚ ?ŝŶƚĞƌǀĞŶƚŝŽŶ 
We congratulate the HF-ACTION group on their latest publication reporting general health status from 
their large multicentre NIH funded randomised controlled of exercise-based cardiac rehabilitation (CR) 
in patients with heart failure with reduced fraction (HFrEF) (1). The accompanying editorial by Flint note 
that although the HF-ACTION trial achieved statistical superiority of exercise training over control in 
health-related quality of life (HRQoL) assessed using generic (EQ-5D) and disease-specific (Kansas City 
Cardiomyopathy Questionnaire (KCCQ)) measures, that these between group differences fail to achieve 
clinical meaningfulness as assessed by the minimally important difference (i.e. > 0.1 for EQ-5D on 0-1 
scale and > 5 for KCCQ) (2).  
However, we disagree with conclusion of Flint that based on the results of this one trial ƚŚĂƚ ?ĐĂƌĚŝĂĐ
ƌĞŚĂďŝůŝƚĂƚŝŽŶŵĂǇďĞĐŽŶƐŝĚĞƌĞĚĂ ?ƚĂŬĞŝƚŽƌůĞĂǀĞŝƚ ?ŽƉƚŝŽŶĨŽƌƐǇŵƉƚŽŵĂƚŝĐ ?ƐƚĂďůĞŽƵƚƉĂƚŝĞŶƚƐǁŝƚŚ
,&ƌ& ? ?/ŶƐƚĞĂĚƚŚĞƌĞƐƵůƚƐŽĨ,&-ACTION trial needs to interpreted in the context of totality of 
randomised trial evidence for exercise-based CR. The most recent 2014 Cochrane review identified 33 
trials that randomised 4,740 patients with predominantly HFrEF to either exercise-based rehabilitation 
intervention or no exercise control (3,4). The 2014 Cochrane review included the HF-ACTION study. 
Eighteen trials reported a validated HRQoL measure, thirteen trials reporting the Minnesota Living with 
Heart Failure Scale (MLwHF). A random effects meta-analysis of MLwHF data up to 12 months follow-up, 
showed a mean pooled improvement of -5.8 (95% CI -9.2 to -2.4) with CR compared to control (see 
Figure 1). Not only was this improvement in HRQoL statistically significant (P = 0.0007) but also achieved 
clinical meaningfulness, a difference of 5 points or larger on the MLwHF being shown to represent a 
clinically important difference (5). Furthermore, the Cochrane authors also showed that pooled data 
across all trials and across all HRQoL measures (including KCCQ findings from HF-ACTION study) was 
associated with mean improvement of 0.46 standard deviations (95% CI: -0.66 to -0.26, P < 0.0001) 
compared to control (Figure 2). Based on the baseline KCCQ scores reported in the HF-ACTION trial, a 
0.5 standard deviation corresponds to a difference of 10 to 10.5 (6), exceeding the KCCQ minimally 
important difference of 5. 
Given statistically significant and clinically important improvements in HRQoL with CR in HFrEF together 
with the other important benefits of reduced the risk of overall (relative risk: 0.75; 95% CI: 0.62 to 0.92, 
P = 0.005) and heart failure-specific hospitalisation (relative risk: 0.61; 95% CI: 0.46 to 0.80, P = 0.0004) 
reported by the Cochrane 2014 review, we contend that CR ƐŚŽƵůĚďĞĐŽŶƐŝĚĞƌĞĚĂ ?ƐŚŽƵůĚƚĂŬĞŝƚĂŶĚ
ŶŽƚůĞĂǀĞŝƚ ?ŽƉƚŝŽŶĨŽƌƐǇŵƉƚŽŵĂƚŝĐ ?ƐƚĂďůĞŽƵƚƉĂƚŝĞŶƚƐǁŝƚŚ,&ƌ& ? 
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Figure 1. Pooled Minnesota Living with Heart Failure score up to 12 months follow up 
 
Figure 2. All quality of life scores up to 12 months follow up. 
 
